<document id="DDI-DrugBank.d190">
    <sentence id="DDI-DrugBank.d190.s1" text="However, since there is an increased risk of bleeding with Xigris, caution should be employed when Xigris is used with other drugs that affect hemostasis.">
        <entity charOffset="59-64" id="DDI-DrugBank.d190.s1.e0" text="Xigris" type="brand" />
        <entity charOffset="99-104" id="DDI-DrugBank.d190.s1.e1" text="Xigris" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d190.s1.e0" e2="DDI-DrugBank.d190.s1.e1" id="DDI-DrugBank.d190.s1.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d190.s3" text="Concomitant use of prophylactic low dose heparin did not appear to affect safety, however, its effects on the efficacy of Xigris have not been evaluated in an adequate and well-controlled clinical trial.">
        <entity charOffset="41-47" id="DDI-DrugBank.d190.s3.e0" text="heparin" type="drug" />
        <entity charOffset="122-127" id="DDI-DrugBank.d190.s3.e1" text="Xigris" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d190.s3.e0" e2="DDI-DrugBank.d190.s3.e1" id="DDI-DrugBank.d190.s3.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d190.s4" text="Drug/Laboratory Test Interaction Because Xigris may affect the APTT assay, Xigris present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).">
        <entity charOffset="41-46" id="DDI-DrugBank.d190.s4.e0" text="Xigris" type="brand" />
        <entity charOffset="75-80" id="DDI-DrugBank.d190.s4.e1" text="Xigris" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d190.s4.e0" e2="DDI-DrugBank.d190.s4.e1" id="DDI-DrugBank.d190.s4.p0" />
    </sentence>
    </document>